PMID: 8413883Sep 1, 1993Paper

Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen

Neurosurgery
G H BaltuchV W Yong

Abstract

We have previously demonstrated that the proliferation of established human glioma cell lines correlated with protein kinase C (PKC) activity and that a relatively selective PKC inhibitor, staurosporine, inhibits glioma cell proliferation. The purpose of this study was to determine whether low-passage glioma cell lines were also sensitive to staurosporine and to compare the antimitotic effects of staurosporine with tamoxifen, an antiestrogen with a known PKC inhibitory effect presently being investigated in the treatment of recurrent glioma. We measured the effects of treatment with staurosporine or tamoxifen on the proliferation rate of five established glioma cell lines (A172, U251, U87, U373, U563) and four low-passage glioma cell lines. The proliferation of all cell lines was inhibited by staurosporine, at an IC50 value (concentration at which activity is 50% inhibited) of approximately 2 nmol/L. All established lines, but only one low-passage line, were susceptible to tamoxifen, with an IC50 value of 10 mumol/L. Three of the four low-passage lines were poorly inhibited by tamoxifen. The IC50 values for the inhibition of cellular proliferation by staurosporine and tamoxifen closely corresponds to the IC50 data for the inhib...Continue Reading

References

Dec 15, 1992·Cancer·H H WangM E Kadin
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V W YongJ P Antel
Nov 21, 1990·Journal of the National Cancer Institute·C A O'Brian, N E Ward
Nov 21, 1990·Journal of the National Cancer Institute·G K SchwartzB C Liu
Jul 15, 1990·Biochemical Pharmacology·J L GrossL E Stephens
Jun 1, 1989·Trends in Pharmacological Sciences·U T Rüegg, G M Burgess
Apr 15, 1988·Biochemical Pharmacology·T NakadateP M Blumberg
Feb 1, 1988·Journal of Neuroscience Research·V W YongS U Kim
Mar 13, 1986·Biochemical and Biophysical Research Communications·T TamaokiF Tomita
Oct 1, 1986·Annals of Neurology·S B HansenJ Wolf-Jensen
May 1, 1993·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·G BaltuchJ G Villemure

❮ Previous
Next ❯

Citations

Oct 1, 1996·Clinical & Experimental Metastasis·J H UhmV W Yong
Jan 1, 1995·Journal of Neuro-oncology·A J YatesJ Van Brocklyn
May 1, 1993·Journal of Neuro-oncology·G H BaltuchV W Yong
Aug 1, 1997·Archives of Pharmacal Research·J S PyenY P Han
Oct 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Nicoletta Galeotti, Carla Ghelardini
Nov 1, 1994·Cellular Signalling·P C Gordge, W J Ryves
Aug 23, 2002·Brain Research. Molecular Brain Research·Naibedya ChattopadhyayEdward M Brown
Sep 24, 1998·Clinical Neurology and Neurosurgery·L MastronardiA Ruggeri
Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·K K ChoM L Rosenblum
Oct 3, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B da RochaG Schwartsmann
Dec 21, 2004·Journal of Neurochemistry·Madhavi S Moodbidri, Neelam V Shirsat
Oct 1, 1994·Neurosurgery·W T CouldwellR E Law
Oct 28, 1998·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·A SaitoK Kakinuma
May 7, 2015·Pharmacology & Therapeutics·Constantinos Alifieris, Dimitrios T Trafalis
Nov 16, 2012·European Journal of Pain : EJP·N Galeotti, C Ghelardini
Mar 1, 2011·International Journal of Radiation Oncology, Biology, Physics·Shilpen PatelPradip Amin
Feb 1, 2000·Toxicology and Applied Pharmacology·M WeiL G Costa
Aug 16, 2016·Journal of Neuropathology and Experimental Neurology·Christopher D GrahamKevin A Roth
Mar 1, 1995·Journal of Neurosurgery·W T CouldwellD R Hinton
Jun 14, 2003·The Journal of Biological Chemistry·Deepika RajeshSteven P Howard
May 1, 1993·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·G BaltuchJ G Villemure
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BroniscerL M Cristófani
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A BrandesM V Fiorentino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.